Medicare Enrolled

Dr. Mikhail Doubrovin, M.D., PH.D.

Nuclear Imaging & Therapy Physician · New York, NY
Practice pattern: Cardiac Imaging — Practice with significant diagnostic imaging and stress testing
Speaking/Promotional
630 W 168TH ST DEPT OF, New York, NY 10032
2123051948
In practice since 2008 (18 years)
NPI: 1801054119 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Doubrovin from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Doubrovin? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Doubrovin

Dr. Mikhail Doubrovin is a nuclear imaging & therapy physician in New York, NY, with 18 years of NPI registration. Based on federal Medicare data, Dr. Doubrovin performed 2,056 Medicare services across 1,199 unique beneficiaries.

Between the years covered by Open Payments, Dr. Doubrovin received a total of $291 from 3 pharmaceutical and/or device companies across 3 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in nuclear imaging & therapy physician. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Doubrovin is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 18 years in practice ▲ Top 30% volume in NY $291 industry payments

Medicare Practice Summary

Medicare Utilization ↗
2,056
Medicare services
Top 30% in NY for nuclear imaging & therapy physician
1,199
Unique beneficiaries
$492
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~114 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Gallium Ga-68 dotatate diagnostic injection
A diagnostic injection of Gallium Ga-68 dotatate used for imaging. The dose specified is 0.1 millicurie.
588 $148 $200
Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries 342 $421 $1,140
Nuclear medicine scan from skull base to mid-thigh with CT
A nuclear medicine imaging study covering the area from the base of the skull to the middle of the thighs, performed alongside a CT scan.
304 $1,497 $8,847
Gallium Ga-68 gozetotide diagnostic injection
A diagnostic injection of the radiopharmaceutical Gallium Ga-68 gozetotide (brand name Illuccix) used for imaging purposes.
150 $840 $3,000
Whole body bone and joint nuclear medicine scan
A nuclear medicine imaging test that uses a radioactive tracer to create pictures of the entire skeleton and joints. This scan helps evaluate bone health and detect abnormalities throughout the body.
137 $34 $190
Lung ventilation and perfusion scan
A nuclear medicine test that uses radioactive tracers to evaluate both air flow (ventilation) and blood flow (perfusion) in the lungs.
84 $44 $240
Whole body nuclear medicine scan with CT
A combined imaging procedure using nuclear medicine and CT scans to visualize the entire body.
74 $1,511 $11,357
SPECT nuclear medicine scan, 1 area
A nuclear medicine imaging test using a single photon emission computed tomography (SPECT) scan to create detailed images of one specific area of the body.
73 $44 $250
Nuclear medicine liver and bile duct scan
A nuclear medicine imaging test to evaluate the liver and bile duct system.
49 $31 $170
SPECT/CT scan, single area
A nuclear medicine imaging study that combines single-photon emission computed tomography (SPECT) with a concurrent CT scan to create detailed images of a single body area.
49 $61 $680
Brain nuclear medicine study with metabolic evaluation
A nuclear medicine imaging test that uses radioactive tracers to evaluate brain metabolism. This procedure helps assess how brain tissues are functioning at a metabolic level.
43 $1,468 $7,700
Radioactive drug therapy through a vein
Administration of a radioactive medication directly into the bloodstream via an intravenous line.
41 $84 $440
Nuclear medicine stomach emptying study
A nuclear medicine test used to assess how quickly the stomach empties its contents.
34 $34 $180
Injection of radioactive material for lymph node identification
A radioactive substance is injected to help locate lymph nodes during imaging procedures.
24 $31 $360
Lung ventilation and perfusion scan
A nuclear medicine test that uses radioactive tracers to evaluate both air flow (ventilation) and blood flow (perfusion) in the lungs.
17 $35 $190
SPECT/CT nuclear medicine scan, multiple areas
A combined nuclear medicine and CT imaging study performed on at least two body areas or through separate acquisitions on the same day.
17 $87 $1,290
Parathyroid nuclear medicine study with SPECT/CT
A nuclear medicine imaging test that uses a radioactive tracer to visualize the parathyroid glands, combined with SPECT and CT scans for detailed anatomical localization.
15 $61 $340
Nuclear medicine kidney blood flow and function study
A nuclear medicine test that evaluates blood flow and function of the kidneys.
15 $59 $310
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
4.9% high complexity
76.5% medium
18.6% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$291
Total received (2023-2024)
Avg $146/year across 2 years
Top 41% in NY for nuclear imaging & therapy physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
3
Companies
3
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$240 (82.5%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$51 (17.5%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$269
2023
$22

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
PROGENICS PHARMACEUTICALS, INC.
$240
GE HEALTHCARE
$29
Top 3 companies account for 100.0% of 2024 payments
All-time payments by company (2023-2024) ›
PROGENICS PHARMACEUTICALS, INC.
$240
GE HEALTHCARE
$29
GE HealthCare
$22
Top 3 companies account for 100.0% of all-time payments
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (82%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in nuclear imaging & therapy physician and does not inherently indicate bias, but patients may wish to be aware.

Looking for a nuclear imaging & therapy physician in New York?
Compare nuclear imaging & therapy physicians in the New York area by procedure volume, costs, and industry payment transparency.
Browse nuclear imaging & therapy physicians nearby

Geographic Context

Nuclear imaging & therapy physicians within 10 mi
22
Per 100K population
1.4
County median income
$104,553
Nearest hospital
NEW YORK STATE PSYCHIATRIC INSTITUTE
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Doubrovin is a cardiac imaging specialist, with above-average Medicare volume (top 30% in NY), with speaking/promotional industry engagement, with 18 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Doubrovin experienced with gallium ga-68 dotatate diagnostic injection?
Based on Medicare claims data, Dr. Doubrovin performed 588 gallium ga-68 dotatate diagnostic injection services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Doubrovin receive payments from pharmaceutical companies?
Yes. Dr. Doubrovin received a total of $291 from 3 companies across 3 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Doubrovin's costs compare to other nuclear imaging & therapy physicians in New York?
Dr. Doubrovin's average Medicare payment per service is $492. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Doubrovin) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →